Navigation Links
ESA's Corona(R) Family of HPLC Detectors, Including the New Corona ultra(TM), Can Now be Controlled by Waters Empower(R) 2 Chromatography Software
Date:5/11/2009

New control option maximizes UHPLC or HPLC productivity via seamless hardware/software interface; Driver available free of charge to all new and existing Corona detector customers

CHELMSFORD, Mass., May 11 /PRNewswire/ -- Integrating a Corona ultra UHPLC detector with a Waters ACQUITY UPLC(R) or Alliance(R) HPLC system is easy thanks to a new Empower 2/Corona detector instrument-control software driver. ESA Biosciences, Inc., a Magellan Biosciences company and leader in novel HPLC systems that improve results for pharmaceutical development and QA/QC, life science, and analytical-chemistry customers worldwide, announced that the driver for Waters' chromatography control and data-analysis platform is available free of charge to new and existing customers. The software driver comes standard with all new Corona detectors. The driver can also be used with ESA's Corona CAD(R) and Corona Plus detectors. Existing customers can download a copy by visiting: http://www.esainc.com/services/software_downloads/empower_driver.

"The development of this driver had its genesis in customer labs, since so many have standardized on both the ESA Corona and Waters platforms. Customers asked for it, and we were pleased to work with Waters to deliver," said Jasmine Gruia-Gray, PhD, president of ESA's life science tools business. "Our product-development goal with the Corona ultra was to make it work seamlessly with the leading U/HPLC brands to help customers streamline their processes, improve productivity, and take full advantage of the power and capabilities inherent in these high-performance systems. The detector is rugged and designed to fit with the other U/HPLC components anywhere within the stack -- no additional bench space is necessary. Now, with the Empower 2 - Corona detector instrument control software, customers can also have single-point system management and control."

Besides excellent sensitivity, the Corona ultra shows consistent inter-analyte response independent of chemical structure. This breakthrough instrument can effectively detect a wide diversity of chemical structures and important classes of molecules -- from small organic molecules, proteins and peptides, to ions, carbohydrates, lipids, and polymers. The Corona ultra makes methods development, validation, and transfer fast and easy for a wide range of life-science research applications and industries: pharmaceutical, chemical, polymer, food and beverage, biofuel, oils, petrochemical, and more. Suited for analytical R&D scientists looking for improved throughput and resolution as well as for those in manufacturing QC requiring real-time quality control, Corona ultra ensures you see the complete analytical picture. For more information, visit www.corona-ultra.com.

About ESA Life Science Tools (www.esainc.com)

A Magellan Biosciences business, ESA Life Science Tools enables answers to pressing analytical challenges for analytical and diagnostics laboratories worldwide. Leaders in HPLC detection, ESA's flexible, applications-focused systems combine specialty detectors with optimized components and consumables -- all designed to achieve maximum performance. ESA's Customer Care experts deliver the highest standard of service to ensure customer confidence, security, knowledge, and support.


'/>"/>
SOURCE ESA Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. 91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs
2. National Patient Advocate Foundation (NPAF) Statement Regarding New FDA Label on Erythropoietin Stimulating Agents (ESAs)
3. ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080
4. Immune Deficiency Foundation Honors Cerda Family and Volunteers From ABCs Extreme Makeover: Home Edition
5. AmLactin(R) Family of Moisturizers Has a New Look
6. Almost Family to Present at Two Upcoming Conferences
7. Dr. Dan Tobin, Family Caregiving Expert, Featured on Caring.com
8. Almost Family Reports First Quarter 2009 Results
9. ABCs Extreme Makeover: Home Edition Helps Family Coping with Primary Immunodeficiency Disease
10. Almost Family, Inc. to Report First Quarter 2009 Financial Results
11. Survey finds nearly half of Americans concerned they or their family may get sick from swine flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: